Company / Book Value per Share
TG Therapeutics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$4.158
FY2025
5-year range
$0.409 / $4.158
FY2021-FY2025
Trend
+183.2%
vs FY2024
Sector context
#115 of 209
Health Care
What the data says
At $4.158, TG Therapeutics, Inc.'s book value per share ranks #115 of 209 in the Health Care sector. Book Value per Share has increased for 3 consecutive years, from $0.409 in FY2022 to $4.158 in FY2025.
Based on SEC 10-K filings.
$4.158 in FY2025 with a 5-year CAGR of -2.6%.
Improved from $1.096 to $4.158 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +116.6%
- 5-Year CAGR
- -2.6%
- 10-Year CAGR
- -
Sector benchmark
#115 of 209 in Health CareTop 55% of 209This company $4.158 Sector average $189.406
▼
-97.8% below sector average
Key checks
Key Insights
- TG Therapeutics, Inc.'s book value per share has grown for 3 consecutive years.
- 5-year CAGR of -2.6%, indicating a declining trend.
- In FY2025, book value per share increased 183.2% year-over-year.
- Ranks #115 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.158 | +183.2% |
| FY2024 | $1.468 | +33.9% |
| FY2023 | $1.096 | +168.1% |
| FY2022 | $0.409 | -75.8% |
| FY2021 | $1.687 | -64.5% |
| FY2020 | $4.748 | +494.4% |
| FY2019 | $0.799 | +143.1% |
| FY2018 | $0.329 | -69.6% |
| FY2017 | $1.079 | +47.6% |
| FY2016 | $0.731 | -67.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026